Categorical characteristic | No. patients n = 87 | Percent |
T-stage | ||
≤ T2a | 17 | 19 |
T2b | 5 | 6 |
≥ T2c | 65 | 75 |
Gleason Score | ||
6 | 12 | 14 |
7 | 49 | 56 |
≥ 8 | 26 | 30 |
Risk group | ||
Low | 0 | 0 |
Intermediate | 14 | 16 |
High | 73 | 84 |
Type of ADT | ||
GnRH agonist | 86 | 99 |
Antiandrogen | 1 | 1 |
Continuous characteristic | Median | Range |
PSA (ng/ml) | 11 | 3.1–91.0 |
Age (yr) | 67 | 50–75 |